<DOC>
	<DOCNO>NCT00372294</DOCNO>
	<brief_summary>Toxoplasmosis , intra cellular parasite , important cause chorioretinitis . The goal treatment arrest multiplication parasite inflammatory active phase . In study investigator try compare efficacy classic regimen ( Pyrimethamine-Sulfadiazine + Prednisolon ) intravitreal Clindamycin &amp; Dexamethasone .</brief_summary>
	<brief_title>To Compare Intravitreal Clindamycin &amp; Dexamethasone With Classic Treatment Toxoplasmic Retinochoroiditis</brief_title>
	<detailed_description />
	<mesh_term>Chorioretinitis</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Sulfadiazine</mesh_term>
	<criteria>Patients Toxoplasmic chorioretinitis Location lesion within zone I retina lesion great 2DD 3+4+ vitreous inflammation zone II III No allergic history use drug No disease Any allergic reaction use medication One eyed patient Partially treat patient</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Toxoplasmosis</keyword>
	<keyword>Chorioretinitis</keyword>
	<keyword>Intravitreal Clindamycin</keyword>
	<keyword>Dexamethasone chorioretinitis</keyword>
	<keyword>Toxoplasmic</keyword>
</DOC>